Site activation refers to the process of preparing and authorizing a clinical research site to begin enrolling participants in a study. This crucial step involves completing all necessary regulatory, administrative, and logistical requirements to ensure the site is fully equipped to conduct the trial according to the protocol.
The activation process typically includes tasks such as obtaining institutional review board (IRB) approval, finalizing contracts and budgets, training study staff, and setting up essential equipment and supplies. Once a site is activated, it can officially start screening and enrolling participants, marking the commencement of the active phase of the clinical trial at that location.
Site activation is a critical milestone in clinical research as it directly impacts the timeline and success of a study. Efficient site activation can accelerate participant enrollment, reduce overall study duration, and potentially lead to faster drug or treatment approvals.
Understanding site activation is crucial for sponsors, CROs, and site staff to effectively manage resources and expectations. It helps identify potential bottlenecks in study initiation, allowing for proactive problem-solving and streamlined processes across multiple research sites.
Europe’s clinical trials market is entering a more practical phase in its approach to competitiveness. With the Clinical Trials Regulation…
The Axcellant team recently attended the International Conference on Nuclear Cardiology (ICNC) in Berlin – one of the most important…
Axcellant is pleased to announce the formation of its Advisory Board - a group of distinguished experts in clinical science,…
Copyright @ 2026 Axcellant